United States Biotechnology & Medical Research

Solid Biosciences Inc (SLDB)

Track

The most recent insider trading activity at Solid Biosciences Inc. occurred on February 18, 2026. Multiple executives and directors, including the CEO and CFO, engaged in a series of sales and proposed sales of company shares. These transactions represent the latest recorded insider activity, with no further trades reported in the subsequent months.

Recent historical selling signal · Dec 2025

Not featured in screeners

Featured in screeners

Recent historical selling signal · Dec 2025

Not featured in screeners

Ticker: SLDB Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

8 activity signals detected for Solid Biosciences Inc

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Solid Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Cumbo Alexander

President and CEO

2 sales — total 193,846 USD

Sale 18 Feb 2026

Value US$4,563,906.55 | Price 135.68 | Shares 87,786

Proposed sale 18 Feb 2026

Value US$2,996,900.95 | Price 162.62 | Shares 75,084

Brooks Gabriel

Officer

1 sale — total 32,395 USD

Proposed sale 18 Feb 2026

Value US$1,830,383.87 | Price 171.65 | Shares 78,967

Hanrahan Jessie

Chief Regulatory Officer

2 sales — total 48,147 USD

Sale 18 Feb 2026

Value US$24,073.52 | Price 5.82 | Shares 4,134

Proposed sale 18 Feb 2026

Value US$24,073.52 | Price 5.82 | Shares 4,134

Ganot Ilan

2 sales — total 31,227 USD

Sale 18 Feb 2026

Value US$15,478.33 | Price 5.82 | Shares 2,658

Proposed sale 18 Feb 2026

Value US$15,748.33 | Price 5.92 | Shares 2,658

Herzich Paul

Officer

2 sales — total 42,114 USD

Proposed sale 18 Feb 2026

Value US$21,057.05 | Price 5.82 | Shares 3,616

Sale 18 Feb 2026

Value US$21,057.05 | Price 5.82 | Shares 3,616

Howton David T

Chief Operating Officer

2 sales — total 86,988 USD

Sale 18 Feb 2026

Value US$43,494.23 | Price 5.82 | Shares 7,469

Proposed sale 18 Feb 2026

Value US$43,494.23 | Price 5.82 | Shares 7,469

Tan Kevin

Officer

2 sales — total 62,938 USD

Proposed sale 18 Feb 2026

Value US$31,469.11 | Price 5.82 | Shares 5,404

Sale 18 Feb 2026

Value US$31,469.11 | Price 5.82 | Shares 5,404

Tan Kevin

CFO & Treasurer

2 sales — total 190,457 USD

Sale 4 Feb 2026

Value US$95,230.61 | Price 6.44 | Shares 14,783

Proposed sale 4 Feb 2026

Value US$95,226.63 | Price 6.44 | Shares 14,783

Howton David T

Chief Operating Officer

2 sales — total 243,422 USD

Sale 4 Feb 2026

Value US$121,713.26 | Price 6.44 | Shares 18,894

Proposed sale 4 Feb 2026

Value US$121,708.27 | Price 6.44 | Shares 18,894

Ganot Ilan

2 sales — total 92,826 USD

Sale 4 Feb 2026

Value US$46,413.89 | Price 6.44 | Shares 7,205

Proposed sale 4 Feb 2026

Value US$46,411.95 | Price 6.44 | Shares 7,205

Cumbo Alexander

President and CEO

2 sales — total 630,172 USD

Sale 4 Feb 2026

Value US$315,092.65 | Price 6.44 | Shares 48,913

Proposed sale 4 Feb 2026

Value US$315,079.69 | Price 6.44 | Shares 48,913

Herzich Paul

Chief Technology Officer

2 sales — total 140,496 USD

Sale 4 Feb 2026

Value US$70,248.92 | Price 6.44 | Shares 10,905

Proposed sale 4 Feb 2026

Value US$70,246.73 | Price 6.44 | Shares 10,905

Hanrahan Jessie

Chief Regulatory Officer

2 sales — total 159,086 USD

Sale 4 Feb 2026

Value US$79,544.58 | Price 6.44 | Shares 12,348

Proposed sale 4 Feb 2026

Value US$79,541.32 | Price 6.44 | Shares 12,348

Brooks Gabriel

Chief Medical Officer

2 sales — total 162,539 USD

Sale 4 Feb 2026

Value US$81,271.01 | Price 6.44 | Shares 12,616

Proposed sale 4 Feb 2026

Value US$81,267.65 | Price 6.44 | Shares 12,616

Hanrahan Jessie

Officer

2 sales — total 341,606 USD

Proposed sale 2 Feb 2026

Value US$170,803.14 | Price 6.44 | Shares 26,535

Sale 2 Feb 2026

Value US$170,803.14 | Price 6.44 | Shares 26,535

Brooks Gabriel

Officer

2 sales — total 364,779 USD

Proposed sale 2 Feb 2026

Value US$182,389.56 | Price 6.44 | Shares 28,335

Sale 2 Feb 2026

Value US$182,389.56 | Price 6.44 | Shares 28,335

Tan Kevin

Officer

2 sales — total 345,494 USD

Proposed sale 2 Feb 2026

Value US$172,747.09 | Price 6.44 | Shares 26,837

Sale 2 Feb 2026

Value US$172,747.09 | Price 6.44 | Shares 26,837

Cumbo Alexander

Officer; Director

2 sales — total 1,033,225 USD

Proposed sale 2 Feb 2026

Value US$516,612.72 | Price 6.44 | Shares 80,258

Sale 2 Feb 2026

Value US$516,612.72 | Price 6.44 | Shares 80,258

Howton David T

Officer

2 sales — total 486,256 USD

Proposed sale 2 Feb 2026

Value US$243,128.15 | Price 6.44 | Shares 37,771

Sale 2 Feb 2026

Value US$243,128.15 | Price 6.44 | Shares 37,771

Herzich Paul

Officer

2 sales — total 337,937 USD

Proposed sale 2 Feb 2026

Value US$168,968.63 | Price 6.44 | Shares 26,250

Sale 2 Feb 2026

Value US$168,968.62 | Price 6.44 | Shares 26,250

Ganot Ilan

1 sale — total 1,259 USD

Sale 28 Jan 2026

Value US$1,258.69 | Price 6.59 | Shares 191

Tan Kevin

Officer

2 sales — total 60,120 USD

Proposed sale 13 Jan 2026

Value US$30,060.08 | Price 5.27 | Shares 5,704

Planned sale 13 Jan 2026

Value US$30,060.08 | Price 5.27 | Shares 5,704

Ganot Ilan

1 sale — total 5,718 USD

Sale 5 Jan 2026

Value US$5,717.79 | Price 5.43 | Shares 1,053

Howton David T

Chief Operating Officer

1 sale — total 25,203 USD

Sale 3 Dec 2025

Value US$25,202.52 | Price 5.11 | Shares 4,932

Hanrahan Jessie

Chief Regulatory Officer

1 sale — total 22,908 USD

Sale 3 Dec 2025

Value US$22,908.13 | Price 5.11 | Shares 4,483

Herzich Paul

Chief Technology Officer

1 sale — total 13,802 USD

Sale 3 Dec 2025

Value US$13,802.11 | Price 5.11 | Shares 2,701

Cumbo Alexander

President and CEO

2 sales — total 110,458 USD

Sale 3 Dec 2025

Value US$55,228.88 | Price 5.11 | Shares 10,808

Proposed sale 3 Dec 2025

Value US$55,228.88 | Price 5.11 | Shares 10,808

Ganot Ilan

1 sale — total 13,505 USD

Sale 10 Nov 2025

Value US$13,505.36 | Price 4.12 | Shares 3,278

Brooks Gabriel

Chief Medical Officer

1 sale — total 17,254 USD

Sale 20 Oct 2025

Value US$17,254.20 | Price 5.96 | Shares 2,895

Kahn Clare

1 purchase — total 9,924 USD

Buy 11 Mar 2025

Value US$9,924.40 | Price 5.34 | Shares 1,860

Bain Capital Life Sciences Investors, LLC

1 purchase — total 4,030,000 USD

Buy 19 Feb 2025

Value US$4,030,000.00 | Price 4.03 | Shares 1,000,000

PERCEPTIVE ADVISORS LLC

1 purchase — total 20,150,000 USD

Buy 19 Feb 2025

Value US$20,150,000.00 | Price 4.03 | Shares 5,000,000

Adage Capital Management, L.P.

1 purchase — total 1,909,240 USD

Buy 18 Feb 2025

Value US$1,909,240.20 | Price 7.56 | Shares 252,545

Tan Kevin

CFO & Treasurer

2 sales — total 25,059 USD

Sale 14 Feb 2025

Value US$12,529.44 | Price 3.96 | Shares 3,164

Proposed sale 14 Feb 2025

Value US$12,529.44 | Price 3.96 | Shares 3,164

Howton David T

Chief Operating Officer

2 sales — total 44,043 USD

Sale 14 Feb 2025

Value US$22,021.56 | Price 3.96 | Shares 5,561

Proposed sale 14 Feb 2025

Value US$22,021.56 | Price 3.96 | Shares 5,561

Ganot Ilan

1 sale — total 6,776 USD

Sale 14 Feb 2025

Value US$6,775.56 | Price 3.96 | Shares 1,711

Hanrahan Jessie

Chief Regulatory Officer

2 sales — total 24,386 USD

Sale 14 Feb 2025

Value US$12,192.84 | Price 3.96 | Shares 3,079

Proposed sale 14 Feb 2025

Value US$12,192.84 | Price 3.96 | Shares 3,079

Cumbo Alexander

President and CEO

2 sales — total 90,011 USD

Sale 14 Feb 2025

Value US$45,005.40 | Price 3.96 | Shares 11,365

Proposed sale 14 Feb 2025

Value US$45,005.40 | Price 3.96 | Shares 11,365

Brooks Gabriel

Chief Medical Officer

1 sale — total 12,894 USD

Sale 14 Feb 2025

Value US$12,893.76 | Price 3.96 | Shares 3,256

Herzich Paul

Chief Technology Officer

2 sales — total 21,289 USD

Sale 14 Feb 2025

Value US$10,644.48 | Price 3.96 | Shares 2,688

Proposed sale 14 Feb 2025

Value US$10,644.48 | Price 3.96 | Shares 2,688

Ganot Ilan

1 sale — total 448 USD

Sale 28 Jan 2025

Value US$447.78 | Price 3.11 | Shares 144

Tan Kevin

CFO & Treasurer

1 sale — total 15,849 USD

Planned sale 10 Jan 2025

Value US$15,849.26 | Price 3.89 | Shares 4,073

Ganot Ilan

1 sale — total 4,551 USD

Sale 6 Jan 2025

Value US$4,551.36 | Price 4.31 | Shares 1,056

Cumbo Alexander

Officer; Director

2 sales — total 124,472 USD

Proposed sale 3 Dec 2024

Value US$62,236.23 | Price 5.60 | Shares 11,114

Sale 3 Dec 2024

Value US$62,236.18 | Price 5.60 | Shares 11,114

Howton David T

Officer

2 sales — total 56,792 USD

Proposed sale 3 Dec 2024

Value US$28,396.05 | Price 5.60 | Shares 5,072

Sale 3 Dec 2024

Value US$28,396.10 | Price 5.60 | Shares 5,072

Hanrahan Jessie

Chief Regulatory Officer

1 sale — total 25,822 USD

Sale 3 Dec 2024

Value US$25,822.45 | Price 5.60 | Shares 4,610

Herzich Paul

Chief Technology Officer

1 sale — total 15,551 USD

Sale 3 Dec 2024

Value US$15,550.64 | Price 5.60 | Shares 2,777

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-02-18	2026-02-18	S Sale	2.3 Cumbo Alexander President and CEO Executive Director	87,786 -33.1% 135.68 US$4,563,907	87,786 -33.1%	135.68	US$4,563,907
2026-02-18	2026-02-18	PrS Proposed sale	2.7 Brooks Gabriel Officer Officer	78,967 171.65 US$1,830,384	78,967	171.65	US$1,830,384
2026-02-18	2026-02-18	PrS Proposed sale	2.3 Cumbo Alexander Officer; Director Executive Director	75,084 162.62 US$2,996,901	75,084	162.62	US$2,996,901
2026-02-18	2026-02-18	S Sale	2.4 Hanrahan Jessie Chief Regulatory Officer Officer	4,134 -5.3% 5.82 US$24,074	4,134 -5.3%	5.82	US$24,074
2026-02-18	2026-02-18	PrS Proposed sale	2.4 Hanrahan Jessie Officer Officer	4,134 5.82 US$24,074	4,134	5.82	US$24,074
2026-02-18	2026-02-18	S Sale	2.5 Ganot Ilan Non-Executive Director	2,658 -8.8% 5.82 US$15,478	2,658 -8.8%	5.82	US$15,478
2026-02-18	2026-02-18	PrS Proposed sale	2.4 Herzich Paul Officer Officer	3,616 5.82 US$21,057	3,616	5.82	US$21,057
2026-02-18	2026-02-18	S Sale	2.4 Herzich Paul Chief Technology Officer Officer	3,616 -4.7% 5.82 US$21,057	3,616 -4.7%	5.82	US$21,057
2026-02-18	2026-02-18	PrS Proposed sale	2.5 Ganot Ilan Director Non-Executive Director	2,658 5.92 US$15,748	2,658	5.92	US$15,748
2026-02-18	2026-02-18	S Sale	2.4 Howton David T Chief Operating Officer Officer	7,469 -6.6% 5.82 US$43,494	7,469 -6.6%	5.82	US$43,494
2026-02-18	2026-02-18	PrS Proposed sale	2.4 Howton David T Officer Officer	7,469 5.82 US$43,494	7,469	5.82	US$43,494
2026-02-18	2026-02-18	PrS Proposed sale	2.1 Tan Kevin Officer Officer	5,404 5.82 US$31,469	5,404	5.82	US$31,469
2026-02-18	2026-02-18	S Sale	2.1 Tan Kevin CFO & Treasurer Officer	5,404 -5.2% 5.82 US$31,469	5,404 -5.2%	5.82	US$31,469
2026-02-06	2026-02-04	S Sale	2.1 Tan Kevin CFO & Treasurer Officer	14,783 -13.6% 6.44 US$95,231	14,783 -13.6%	6.44	US$95,231
2026-02-06	2026-02-04	S Sale	2.4 Howton David T Chief Operating Officer Officer	18,894 -16.2% 6.44 US$121,713	18,894 -16.2%	6.44	US$121,713
2026-02-06	2026-02-04	S Sale	2.5 Ganot Ilan Non-Executive Director	7,205 -22.2% 6.44 US$46,414	7,205 -22.2%	6.44	US$46,414
2026-02-06	2026-02-04	S Sale	2.3 Cumbo Alexander President and CEO Executive Director	48,913 -18.1% 6.44 US$315,093	48,913 -18.1%	6.44	US$315,093
2026-02-06	2026-02-04	S Sale	2.4 Herzich Paul Chief Technology Officer Officer	10,905 -13.6% 6.44 US$70,249	10,905 -13.6%	6.44	US$70,249
2026-02-06	2026-02-04	S Sale	2.4 Hanrahan Jessie Chief Regulatory Officer Officer	12,348 -14.9% 6.44 US$79,545	12,348 -14.9%	6.44	US$79,545
2026-02-06	2026-02-04	S Sale	2.7 Brooks Gabriel Chief Medical Officer Officer	12,616 -13.0% 6.44 US$81,271	12,616 -13.0%	6.44	US$81,271
2026-02-04	2026-02-04	PrS Proposed sale	2.7 Brooks Gabriel Officer Officer	12,616 6.44 US$81,268	12,616	6.44	US$81,268
2026-02-04	2026-02-04	PrS Proposed sale	2.4 Hanrahan Jessie Officer Officer	12,348 6.44 US$79,541	12,348	6.44	US$79,541
2026-02-04	2026-02-04	PrS Proposed sale	2.5 Ganot Ilan Director Non-Executive Director	7,205 6.44 US$46,412	7,205	6.44	US$46,412
2026-02-04	2026-02-04	PrS Proposed sale	2.1 Tan Kevin Officer Officer	14,783 6.44 US$95,227	14,783	6.44	US$95,227
2026-02-04	2026-02-04	PrS Proposed sale	2.4 Herzich Paul Officer Officer	10,905 6.44 US$70,247	10,905	6.44	US$70,247
2026-02-04	2026-02-04	PrS Proposed sale	2.3 Cumbo Alexander Officer; Director Executive Director	48,913 6.44 US$315,080	48,913	6.44	US$315,080
2026-02-04	2026-02-04	PrS Proposed sale	2.4 Howton David T Officer Officer	18,894 6.44 US$121,708	18,894	6.44	US$121,708
2026-02-02	2026-02-02	PrS Proposed sale	2.4 Hanrahan Jessie Officer Officer	26,535 6.44 US$170,803	26,535	6.44	US$170,803
2026-02-02	2026-02-02	PrS Proposed sale	2.7 Brooks Gabriel Officer Officer	28,335 6.44 US$182,390	28,335	6.44	US$182,390
2026-02-02	2026-02-02	PrS Proposed sale	2.1 Tan Kevin Officer Officer	26,837 6.44 US$172,747	26,837	6.44	US$172,747
2026-02-02	2026-02-02	PrS Proposed sale	2.3 Cumbo Alexander Officer; Director Executive Director	80,258 6.44 US$516,613	80,258	6.44	US$516,613
2026-02-02	2026-02-02	PrS Proposed sale	2.4 Howton David T Officer Officer	37,771 6.44 US$243,128	37,771	6.44	US$243,128
2026-02-02	2026-02-02	PrS Proposed sale	2.4 Herzich Paul Officer Officer	26,250 6.44 US$168,969	26,250	6.44	US$168,969
2026-02-02	2026-02-02	S Sale	2.7 Brooks Gabriel Chief Medical Officer Officer	28,335 -22.7% 6.44 US$182,390	28,335 -22.7%	6.44	US$182,390
2026-02-02	2026-02-02	S Sale	2.4 Howton David T Chief Operating Officer Officer	37,771 -24.4% 6.44 US$243,128	37,771 -24.4%	6.44	US$243,128
2026-02-02	2026-02-02	S Sale	2.3 Cumbo Alexander President and CEO Executive Director	80,258 -22.9% 6.44 US$516,613	80,258 -22.9%	6.44	US$516,613
2026-02-02	2026-02-02	S Sale	2.4 Hanrahan Jessie Chief Regulatory Officer Officer	26,535 -24.3% 6.44 US$170,803	26,535 -24.3%	6.44	US$170,803
2026-02-02	2026-02-02	S Sale	2.4 Herzich Paul Chief Technology Officer Officer	26,250 -24.7% 6.44 US$168,969	26,250 -24.7%	6.44	US$168,969
2026-02-02	2026-02-02	S Sale	2.1 Tan Kevin CFO & Treasurer Officer	26,837 -19.8% 6.44 US$172,747	26,837 -19.8%	6.44	US$172,747
2026-01-30	2026-01-28	S Sale	2.5 Ganot Ilan Non-Executive Director	191 -1.1% 6.59 US$1,259	191 -1.1%	6.59	US$1,259
2026-01-13	2026-01-13	PrS Proposed sale	2.1 Tan Kevin Officer Officer	5,704 5.27 US$30,060	5,704	5.27	US$30,060
2026-01-13	2026-01-13	PlS Planned sale	2.1 Tan Kevin CFO & Treasurer Officer	5,704 -11.0% 5.27 US$30,060	5,704 -11.0%	5.27	US$30,060
2026-01-06	2026-01-05	S Sale	2.5 Ganot Ilan Non-Executive Director	1,053 -5.7% 5.43 US$5,718	1,053 -5.7%	5.43	US$5,718
2025-12-04	2025-12-03	S Sale	2.4 Howton David T Chief Operating Officer Officer	4,932 -13.0% 5.11 US$25,203	4,932 -13.0%	5.11	US$25,203
2025-12-04	2025-12-03	S Sale	2.4 Hanrahan Jessie Chief Regulatory Officer Officer	4,483 -14.4% 5.11 US$22,908	4,483 -14.4%	5.11	US$22,908
2025-12-04	2025-12-03	S Sale	2.4 Herzich Paul Chief Technology Officer Officer	2,701 -9.2% 5.11 US$13,802	2,701 -9.2%	5.11	US$13,802
2025-12-04	2025-12-03	S Sale	2.3 Cumbo Alexander President and CEO Executive Director	10,808 -11.7% 5.11 US$55,229	10,808 -11.7%	5.11	US$55,229
2025-12-03	2025-12-03	PrS Proposed sale	2.3 Cumbo Alexander Officer; Director Executive Director	10,808 5.11 US$55,229	10,808	5.11	US$55,229
2025-11-13	2025-11-10	S Sale	2.5 Ganot Ilan Non-Executive Director	3,278 -3.3% 4.12 US$13,505	3,278 -3.3%	4.12	US$13,505
2025-10-21	2025-10-20	S Sale	2.7 Brooks Gabriel Chief Medical Officer Officer	2,895 -7.9% 5.96 US$17,254	2,895 -7.9%	5.96	US$17,254
2025-03-13	2025-03-11	B Purchase	3.1 Kahn Clare Non-Executive Director	1,860 +169.1% 5.34 US$9,924	1,860 +169.1%	5.34	US$9,924
2025-02-21	2025-02-19	B Purchase	2.7 Bain Capital Life Sciences Investors, LLC Large shareholder	1,000,000 +24.8% 4.03 US$4,030,000	1,000,000 +24.8%	4.03	US$4,030,000
2025-02-21	2025-02-19	B Purchase	2.7 PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder	5,000,000 +73.2% 4.03 US$20,150,000	5,000,000 +73.2%	4.03	US$20,150,000
2025-02-19	2025-02-18	B Purchase	0.5 Adage Capital Management, L.P. Large shareholder	252,545 +6.3% 7.56 US$1,909,240	252,545 +6.3%	7.56	US$1,909,240
2025-02-18	2025-02-14	S Sale	2.1 Tan Kevin CFO & Treasurer Officer	3,164 -8.9% 3.96 US$12,529	3,164 -8.9%	3.96	US$12,529
2025-02-18	2025-02-14	S Sale	2.4 Howton David T Chief Operating Officer Officer	5,561 -18.3% 3.96 US$22,022	5,561 -18.3%	3.96	US$22,022
2025-02-18	2025-02-14	S Sale	2.5 Ganot Ilan Non-Executive Director	1,711 -10.3% 3.96 US$6,776	1,711 -10.3%	3.96	US$6,776
2025-02-18	2025-02-14	S Sale	2.4 Hanrahan Jessie Chief Regulatory Officer Officer	3,079 -13.8% 3.96 US$12,193	3,079 -13.8%	3.96	US$12,193
2025-02-18	2025-02-14	S Sale	2.3 Cumbo Alexander President and CEO Executive Director	11,365 -15.8% 3.96 US$45,005	11,365 -15.8%	3.96	US$45,005
2025-02-18	2025-02-14	S Sale	2.7 Brooks Gabriel Chief Medical Officer Officer	3,256 -12.5% 3.96 US$12,894	3,256 -12.5%	3.96	US$12,894
2025-02-18	2025-02-14	S Sale	2.4 Herzich Paul Chief Technology Officer Officer	2,688 -12.8% 3.96 US$10,644	2,688 -12.8%	3.96	US$10,644
2025-02-14	2025-02-14	PrS Proposed sale	2.4 Howton David T Officer Officer	5,561 3.96 US$22,022	5,561	3.96	US$22,022
2025-02-14	2025-02-14	PrS Proposed sale	2.4 Herzich Paul Officer Officer	2,688 3.96 US$10,644	2,688	3.96	US$10,644
2025-02-14	2025-02-14	PrS Proposed sale	2.1 Tan Kevin Officer Officer	3,164 3.96 US$12,529	3,164	3.96	US$12,529
2025-02-14	2025-02-14	PrS Proposed sale	2.3 Cumbo Alexander Officer; Director Executive Director	11,365 3.96 US$45,005	11,365	3.96	US$45,005
2025-02-14	2025-02-14	PrS Proposed sale	2.4 Hanrahan Jessie Officer Officer	3,079 3.96 US$12,193	3,079	3.96	US$12,193
2025-01-29	2025-01-28	S Sale	2.5 Ganot Ilan Non-Executive Director	144 -1.2% 3.11 US$448	144 -1.2%	3.11	US$448
2025-01-13	2025-01-10	PlS Planned sale	2.1 Tan Kevin CFO & Treasurer Officer	4,073 -14.1% 3.89 US$15,849	4,073 -14.1%	3.89	US$15,849
2025-01-07	2025-01-06	S Sale	2.5 Ganot Ilan Non-Executive Director	1,056 -8.4% 4.31 US$4,551	1,056 -8.4%	4.31	US$4,551
2024-12-05	2024-12-03	PrS Proposed sale	2.3 Cumbo Alexander Officer; Director Executive Director	11,114 5.60 US$62,236	11,114	5.60	US$62,236
2024-12-04	2024-12-03	PrS Proposed sale	2.4 Howton David T Officer Officer	5,072 5.60 US$28,396	5,072	5.60	US$28,396
2024-12-04	2024-12-03	S Sale	2.4 Hanrahan Jessie Chief Regulatory Officer Officer	4,610 -24.5% 5.60 US$25,822	4,610 -24.5%	5.60	US$25,822
2024-12-04	2024-12-03	S Sale	2.3 Cumbo Alexander President and CEO Executive Director	11,114 -22.4% 5.60 US$62,236	11,114 -22.4%	5.60	US$62,236
2024-12-04	2024-12-03	S Sale	2.4 Howton David T Chief Operating Officer Officer	5,072 -24.5% 5.60 US$28,396	5,072 -24.5%	5.60	US$28,396
2024-12-04	2024-12-03	S Sale	2.4 Herzich Paul Chief Technology Officer Officer	2,777 -18.6% 5.60 US$15,551	2,777 -18.6%	5.60	US$15,551

Explore more

More insider trading research around Solid Biosciences Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

Solid Biosciences Inc (SLDB)

Track

Featured in screeners

Upgrade for signal details

Transactions

Insider

Sort by

Trades

Explore more